References
- FerlayJParkinDMSteliarova-FoucherEEstimates of cancer incidence and mortality in Europe in 2008Eur J Cancer201046476578120116997
- BonoAVThe global state of prostate cancer: epidemiology and screening in the second millenniumBJU Int200494Suppl 312
- National Cancer InstituteProstate Cancer Treatment (PDQ®) – Health Professional Version. General Information About Prostate Cancer2015 [updated March 31, 2017; cited September 2, 2015] Available from: http://www.cancer.gov/cancertopics/pdq/treatment/prostate/HealthProfessional/Accessed June 1, 2018
- ItoKProstate cancer in Asian menNat Rev Urol201411419721224595118
- CussenotOValeriAHeterogeneity in genetic susceptibility to prostate cancerEur J Int Med2001121116
- FariaEFCarvalhalGFVieiraRASilvaTBMauadECCarvalhoALProgram for prostate cancer screening using a mobile unit: results from BrazilUrology20107651052105720472277
- GillilandFDKeyCRProstate cancer in American Indians, New Mexico, 1969–1994J Urol19981598938989474177
- FacinaTEstimativa 2012 – Incidencia de Cancer no BrasilRevista Brasileira de Cancerologia201157557
- De LimaMMJrde LimaMMGranjaFProstate cancer in Amazon native Indian: a case reportAsian Pharm Tech2014215
- CandasBLabrieFGomezJLRelationship among initial serum prostate specific antigen, prostate specific antigen progression and prostate cancer detection at repeat screening visitsJ Urol2006175251051616406983
- McGreevyKRodgersKLipsitzSBissadaNHoelDImpact of race and baseline PSA on longitudinal PSAInt J Cancer200611871773177616231314
- BalkSPKoYJBubleyGJBiology of prostate-specific antigenJ Clin Oncol200321238339112525533
- MillerBAChuKCHankeyBFRiesLACancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.SCancer Causes Control200819322725618066673
- DuffyMJPSA in screening for prostate cancer: more good than harm or more harm than good?Adv Clin Chem20146612325344984
- StenmanUHHakamaMKnektPAromaaATeppoLLeinonenJSerum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancerLancet19943448937159415987527116
- ThompsonIPaulerDGoodmanPPrevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliterN Engl J Med2004350222239224615163773
- CatalonaWJRichieJPAhmannFRComparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicentre clinical trial of 6,630 menJ Urol19941515128312907512659
- LeeRLocalioARArmstrongKA meta-analysis of the performance characteristics of the free prostate-specific antigen testUrology200667476276816600352
- MieleMEPercent free PSA as an additional measure in a prostate cancer screenClin Lab Sci200114210210715625982
- CollinsGNLeeRJMcKelvieGBRogersACHehirMRelationship between prostate specific antigen, prostate volume and age in the benign prostateBrit J Urol19937144454507684650
- OesterlingJEJacobsenSJChuteCGSerum prostate specific antigen in a community based population of healthy men: establishment of age-specific reference rangesJAMA199327078608647688054
- LudererAAChenYTSorianoTFMeasurement of the proportion of free to total prostate specific antigen improves diagnostic performance of prostate specific antigen in the diagnostic grey zone of total prostate specific antigenUrology19954621871947542820
- OesterlingJEJacobsenSJKleeGGFree, complexed and total prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratiosJ Urol19951543109010957543605
- LuboldtHJSchindlerFSRubbenHAge-specific reference ranges for prostate-specific antigen as a marker for prostate cancerEur Urol200753848
- KalishLAMcKinlayJBSerum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSAUrology19995461022102710604702
- De Lima JuniorMMReisLOFerreiraUUnraveling Brazilian Indian Population prostate good health: clinical, anthropometric and genetic featuresInt Braz J Urol201541234435226005978
- DalkinBLAhmannFRKoppJBProstate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinomaJ Urol19931506183718397693980
- CrawfordEDReport on the 1993 prostate cancer awareness weekAbstract presented at: Annual Meeting of the American Urological AssociationMay 14–19, 1994San Francisco, CA, USA
- BergerAPCheliCLevineRKlockerHBartschGHorningerWImpact of age on complexed PSA levels in men with total PSA levels of up to 20 ng/mLUrology200362584084414624905
- DeAntoniEPCrawfordEDOesterlingJEAge and race-specific reference ranges for prostate-specific antigen from a large community-based studyUrology19964822342398753735
- MoulJWSesterhennIAConellyRRProstate specific antigen values at the time of prostate cancer diagnosis in African-American menJAMA199527416127712817563532
- MartinBCheliCPollardSSimilar age-specific PSA, complexed PSA, and percent cPSA levels among African-American and white men of southern Louisiana. Prostate-specific antigenUrology200361237537912597951
- SawSAwTCAge-related reference intervals for free and total prostate-specific antigen in a Singaporean populationPathology200032424524911186419
- KimJHLeeSWKimJHAssociation between obesity, prostate-specific antigen level and prostate-specific antigen density in men with a negative prostate biopsyJ Int Med Res201442382182724743874
- HeDWangMChenXEthnic differences in distribution of serum prostate-specific antigen: a study in a healthy Chinese male populationUrology200463472272615072888